A vaccine developed by scientists at the Public Health Agency of Canada is now available in enough doses to launch the first ever human safety trial of an ebola vaccine.
NewLink Genetics Corp has lined up two contract manufacturing companies and possibly a third and will be able to produce tens of thousands of doses of the vaccine within “the next month or two,” its chief executive said on Wednesday.
(READ the story from Reuters News)
Photo of vaccination by US Army